Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Interview: Mark Middleton, CEO, Icon

Mark Middleton is group CEO of Icon, the Australian cancer care specialist which is making inroads into Singapore and China. He speaks to Healthcare Nova about the group's strategy to date, how it is expanding into South East Asia, and its plans for expansion.

Getting to grips with UHC in Indonesia – and what it might mean for India

Universal health coverage is being implemented in Indonesia, with full coverage planned for 2019. Meanwhile discussions are taking place in India about how to cover the nation’s 1.3bn residents. Healthcare Nova speaks to private equity firm Creador which has invested in healthcare in both countries. “What’s happening in Indonesia is a work in progress, we’re […]

Pihlajalinna’s results boosted by high sales and delayed reform

Better-than-expected sales in primary and social care have boosted the Finnish provider Pihlajalinna’s 2017 revenue and the company plans to make more acquisitions as part of its expansion. The EBITDA for 2017 increased by 20% year on year to €33.3m and earnings per share also rose by 18% to €0.46 during the same period. The […]

Organic growth powers Medicover

Strong organic growth at 14.5% was at the core of a robust set of results for German, East-European and Indian outpatient, hospital and lab group Medicover which announced its maiden results post its summer 2017 IPO.

European shopping malls – the best place to build primary care clinics?

Sweden-based Minutkliniken is pioneering an American idea in Europe - shopping mall-based clinics, with appointment free drop-in consultations, diagnosis and prescriptions for minor ailments, along with health checkups. Healthcare Europa catches up with founder and Chief Medical Officer Ron Liebkind to find out more about his business strategy and plans to take the Minuteclinic model run by CVS in the USA to Europe.

Turkish hospital lands on stock market with a low multiple

Turkish hospital chain Medical Park Group has completed its IPO raising €294m for 36% of the €840m valued company. The EBITDA multiple is a far cry from previous healthcare transactions in Turkey, but a source tells Healthcare Europa it's a fair one.

Ober Scharrer “priced aggressively” as sale expected by May

We've been keeping our eye on German ophthalmology chain Ober Scharrer for months, and at long last we hear a sale looks imminent. Healthcare Europa speaks to a source in Germany about who is still in the running, and whether the prospective price could be putting buyers off.

Unitary insurance could smash operator profit margins

Many German private operators would see their margins savaged if the new coalition moves to unitary mandatory insurance for all Germans. The proposed new grand coalition between the Christian Democrats and the Social Democrats includes a commission due to report at the end of 2019 on whether Germany should move to a unified insurance system. […]

Find Us